PATENT CLAIM ANALYSIS

Application Number: 16412284
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "562000"]

Abstract:
A pharmaceutical composition and method for providing a reduction in side effects for human patients in need of therapy comprising the administration of a pharmaceutical composition comprising acetylcysteine is disclosed.

Claim (Index 16):
The method of  claim 12 , wherein the first dose is administered over a time period of about 4 hours.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 100.0
- Lexical Diversity: 1.29167
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13188152', '14225345', '13757721', '14153978', '13406175']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8132736653557124
- 35 USC 102 Novelty (BERT): 0.5519487444537972
- Combined Prediction Score: 0.7871411732655209
- Mean Citation Score: 380.933756
- Max Citation Score: 459.8708
- Similarity Product: 272.2247135496616

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test